Empirical Finance LLC Decreases Stock Holdings in Humana Inc. (NYSE:HUM)

Empirical Finance LLC cut its stake in shares of Humana Inc. (NYSE:HUM) by 1.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 4,276 shares of the insurance provider’s stock after selling 47 shares during the period. Empirical Finance LLC’s holdings in Humana were worth $1,085,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. State Street Corp raised its position in shares of Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after purchasing an additional 53,272 shares during the last quarter. FMR LLC increased its stake in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after acquiring an additional 187,903 shares during the last quarter. Ontario Teachers Pension Plan Board lifted its position in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after acquiring an additional 71,910 shares in the last quarter. Finally, Sanders Capital LLC boosted its stake in shares of Humana by 1.0% in the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock worth $370,060,000 after acquiring an additional 11,923 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on HUM. Truist Financial raised their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Barclays boosted their price target on shares of Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 22nd. TD Cowen increased their price objective on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Morgan Stanley boosted their target price on Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, Piper Sandler increased their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $297.68.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

Humana Stock Down 2.7 %

Humana stock opened at $266.91 on Tuesday. The company has a market capitalization of $32.14 billion, a PE ratio of 23.64, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The firm has a 50 day moving average price of $274.21 and a 200 day moving average price of $297.52.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.